Strain-specific role of RNAs in prion replication

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10494-10504

  Saá, Paula ^a,b   Sferrazza, Gian Franco ^a,c   Ottenberg, Gregory ^a,c   Oelschlegel, Anja M ^a   Dorsey, Kerri ^b   Lasmézas, Corinne I ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b AMERICAN RED CROSS   (United States)

^c OPKO Health Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEASE; SYNTHETIC DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CATALYST; CELL ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INOCULATION; LIMB WEAKNESS; MOUSE; NONHUMAN; NUCLEIC ACID ANALYSIS; PARESIS; PHENOTYPE; PRION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BIOLOGICAL ASSAY; BRAIN; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; PRION DISEASES; PRIONS; PROTEIN FOLDING; RIBONUCLEASE, PANCREATIC; RNA; SCRAPIE; SPECIES SPECIFICITY; THERMOLYSIN;

MURINAE; MUS;

EID: 84869073820     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01286-12     Document Type: Article

References (40)

1. Bessen RA, Marsh RF. 1992. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66:2096-2101.
2. Borchelt DR, Taraboulos A, Prusiner SB. 1992. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267: 16188-16199.
3. Browning S, et al. 2011. Abrogation of complex glycosylation by swainsonine results in strainand cell-specific inhibition of prion replication. J. Biol. Chem. 286:40962-40973.
4. Bruce ME. 1993. Scrapie strain variation and mutation. Br. Med. Bull. 49:822-838.
5. Castilla J, Saa P, Hetz C, Soto C. 2005. In vitro generation of infectious scrapie prions. Cell 121:195-206.
6. Chen SG, et al. 1995. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270:19173-19180.
7. Couzin J. 2004. Biomedicine. An end to the prion debate? Don't count on it. Science 305:589.
8. Cronier S, et al. 2008. Detection and characterization of proteinase Ksensitive disease-related prion protein with thermolysin. Biochem. J. 416: 297-305.
9. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U. S. A. 104:9741-9746.
10. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. 2010. Speciesdependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49:3928-3934.
11. Dickinson AG, Outram GW, Taylor DM, Foster JD. 1989. Further evidence that scrapie agent has an independent genome, p 446-459. In Court LA, Dormont D, Brown P, Kingsbury DT (ed), Unconventional virus diseases of the central nervous system (Paris 2-6 December 1986). CEA Diffusion, Fontenay-aux Roses, France.
12. Dinger ME, Mercer TR, Mattick JS. 2008. RNAs as extracellular signaling molecules. J. Mol. Endocrinol. 40:151-159.
13. Doi S, et al. 1988. Western blot detection of scrapie-associated fibril protein in tissues outside the central nervous system from preclinical scrapie-infected mice. J. Gen. Virol. 69:955-960.
14. Dron M, et al. 2010. Endogenous proteolytic cleavage of diseaseassociated prion protein to produce C2 fragments is strongly celland tissue-dependent. J. Biol. Chem. 285:10252-10264.
15. Gonzalez-Montalban N, Makarava N, Savtchenko R, Baskakov IV. 2011. Relationship between conformational stability and amplification efficiency of prions. Biochemistry 50:7933-7940.
16. Goold R, et al. 2011. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat. Commun. 2:281.
17. Jeong BH, et al. 2009. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases. J. Neuropathol. Exp. Neurol. 68:870-879.
18. Karapetyan YE, et al. 2009. Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One 4:e5730. doi:10.1371/journal.pone.0005730.
19. Kim JI, et al. 2010. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem. 285:14083-14087.
20. Lasmézas CI, et al. 2001. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc. Natl. Acad. Sci. U. S. A. 98: 4142-4147.
21. Legname G, et al. 2004. Synthetic mammalian prions. Science 305:673-676.
22. Mahal SP, et al. 2007. Prion strain discrimination in cell culture: the cell panel assay. Proc. Natl. Acad. Sci. U. S. A. 104:20908-20913.
23. Mahal SP, Browning S, Li J, Suponitsky-Kroyter I, Weissmann C. 2010. Transfer of a prion strain to different hosts leads to emergence of strain variants. Proc. Natl. Acad. Sci. U. S. A. 107:22653-22658.
24. Marijanovic Z, Caputo A, Campana V, Zurzolo C. 2009. Identification of an intracellular site of prion conversion. PLoS Pathog. 5:e1000426. doi:10.1371/journal.ppat.1000426.
25. Oelschlegel AM, Fallahi M, Ortiz-Umpierre S, Weissmann C. 2012. The extended cell panel assay characterizes the relationship of prion strains RML, 79A, and 139A and reveals conversion of 139A to 79A-like prions in cell culture. J. Virol. 86:5297-5303.
26. Pan KM, et al. 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 90:10962-10966.
27. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
28. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-496.
29. Safar J, et al. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:1157-1165.
30. Smirnovas V, et al. 2011. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 18:504-506.
31. Taraboulos A, et al. 1995. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129:121-132.
32. Wadsworth JD, et al. 2001. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171-180.
33. Wang F, Wang X, Yuan CG, Ma J. 2010. Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135.
34. Wang F, et al. 2012. Genetic informational RNA is not required for recombinant prion infectivity. J. Virol. 86:1874-1876.
35. Weissmann C. 1991. A 'unified theory' of prion propagation. Nature 352:679-683.
36. Weissmann C, Li J, Mahal SP, Browning S. 2011. Prions on the move. EMBO Rep. 12:1109-1117.
37. Will RG, et al. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
38. Yadavalli R, et al. 2004. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J. Biol. Chem. 279:21948-21956.
39. Ying YS, Anderson RG, Rothberg KG. 1992. Each caveola contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harbor Symp. Quant. Biol. 57:593-604.
40. Zhu H, Fan GC. 2011. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am. J. Cardiovasc. Dis. 1:138-149.